For the Inventor, By the Inventor

Enter inventor name

Berlin, Germany

Rosemarie Lichtner

USPTO Granted Patents = 18 (Patent Applications = 1)

Average Co-Inventor Count = 7.4

ph-index = 4

Forward Citations = 48(Granted Patents)

Company Filing History:

15 out of 1,384

Schering Aktiengesellschaft

Bayer Schering Pharma Ag

Years Active: 1999-2010

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7700621 - 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations (2010-04-20),

2. 7645891 - 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations (2010-01-12),

3. 7538100 - 17α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations (2009-05-26),

4. 7378406 - Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases (2008-05-27),

5. 7145015 - Benzocycloheptenes, process for their production, pharmaceutical preparations that contain that latter as well as their use for the production of pharmaceutical agents (2006-12-05),

6. 7125893 - 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations (2006-10-24),

7. 7074829 - Antiestrogens, process for their production and their pharmaceutical use (2006-07-11),

8. 7018994 - 17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, USE OF THE 17α-ALKYL-17β-OXY-ESTRATRIENES FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS AS WELL AS PHARMACEUTICAL PREPARATIONS (2006-03-28),

9. 6878750 - Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents (2005-04-12),

10. 6790842 - 11&bgr; LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11&bgr; LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS (2004-09-14),

11. 6780855 - 11&bgr;-HALOGEN-7&agr;-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11&bgr;-HALOGEN-7&agr;-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS (2004-08-24),

12. 6559181 - Antiestrogens, process for their protection and their pharmaceutical use (2003-05-06),

13. 6495607 - Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents (2002-12-17),

14. 6288051 - 7 &agr;-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7 &agr;(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents (2001-09-11),

15. 6271403 - 7&agr;-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7&agr;-(xi-aminoalkyl-estratrienes as well as their use for the production of pharmaceutical agents (2001-08-07),

Title: Rosemarie Lichtner: Pioneer in Pharmaceutical Innovations

Introduction:

Rosemarie Lichtner, a renowned inventor based in Berlin, DE, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 18 patents, Lichtner's innovations have led to groundbreaking advancements in the treatment of various diseases.

Latest Patents:

Lichtner's latest patents revolve around 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives. These compounds, described by a specific formula, exhibit interactions with tubulin by stabilizing microtubules, influencing cell division in a phase-specific manner. They have shown promise in treating malignant tumors such as ovarian, stomach, colon, breast carcinomas, among others. Additionally, they hold potential for anti-angiogenesis therapy and treatment of chronic inflammatory diseases like psoriasis and arthritis.

Career Highlights:

Throughout his career, Lichtner has been associated with esteemed companies such as Schering Aktiengesellschaft and Bayer Schering Pharma AG. His work within these organizations has been instrumental in the development and commercialization of innovative pharmaceutical solutions aimed at improving patient outcomes.

Collaborations:

Lichtner has collaborated closely with notable professionals in the industry, including Rolf Bohlmann and Nikolaus Heinrich. Together, they have spearheaded research initiatives that have paved the way for novel treatment modalities and therapeutic interventions.

Conclusion:

In conclusion, Rosemarie Lichtner's inventive spirit and dedication to advancing pharmaceutical science have positioned him as a pioneer in the field. His patents and collaborations stand as a testament to his expertise and unwavering commitment to catalyzing positive change in the realm of healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…